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Loop and associates3 suggested that thin patients may
actually be at a higher risk after coronary artery opera-
tions. The effect of small body size on the incidence of
complications, length of stay, and mortality after car-
diac operations has not been extensively studied. We
used prospectively collected data compiled on 5168
consecutive patients undergoing cardiac operations at
Brigham and Women’s Hospital from January 1993 to
December 1997 to assess the independent contribution
of body size to morbidity and mortality after cardiac
operations.
Malnutrition has also been reported to increase the
morbidity and mortality after cardiac operations.4 One
objective measure of malnutrition is serum albumin.
Preoperative serum albumin levels have been found to
be strong independent predictors of morbidity and mor-
tality in a recent large study of patients undergoing non-
I t is widely assumed that obese patients have a signif-icantly increased risk for major complications after
cardiac operations. However, recent studies have shown
no significant association between obesity and major
cardiac surgical morbidity and mortality.1,2 A study by
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cardiac surgery.5 We used the preoperative serum albu-
min level to determine the degree to which hypoalbu-
minemia contributed to postoperative morbidity and
mortality. In addition, we assessed whether any associ-
ation between body mass index (BMI) and surgical out-
come was dependent on the preoperative nutritional
status as measured by serum albumin.
Patients and methods
Data were collected prospectively from 5168 consecutive
patients undergoing coronary artery bypass grafting (CABG)
or valve surgery, or both, at Brigham and Women’s Hospital
between 1993 and 1997. Patients with other concomitant sur-
gical procedures were excluded from the study (eg, carotid
endarterectomy, aortic procedures, transplantation, transmyo-
cardial laser procedures, and congenital abnormalities).
Patients undergoing primary as well as reoperative surgery
were included in the study. The degree of thinness or obesity
was assessed by the BMI.6 The BMI is defined as the weight
in kilograms divided by the height in meters squared. Of the
obesity indexes, BMI correlates least with height and most
with more direct measurements of percent body fat.7 A BMI
of less than 20 was defined as our high-risk thin group. This
corresponds to a weight more than 25% below the ideal body
weight for an individual height.8 A BMI of more than 30 was
defined as our high-risk obese group. This corresponds to 1
standard deviation above the mean BMI.1 Preoperative serum
albumin was collected from all patients.
All operations were performed with systemic hypothermia
(30°C) and cold blood cardioplegia. Intraoperative trans-
esophageal and epiaortic ultrasound (or both) was used in
patients selectively. Cardiopulmonary bypass flow rates were
between 1.8 and 2.0 L · min–1 · m–2, and mean arterial pres-
sure was maintained between 40 and 80 mm Hg. Patients
with known cerebrovascular disease were maintained at the
higher end of this pressure spectrum. Proximal and distal
anastomoses were performed in the majority of CABG cases
by means of a single crossclamping technique.
Postoperative neurologic events were verified by computed
tomographic scanning and a neurologic consultation and
included both transient ischemic attacks and strokes. A low
cardiac output state was defined as the need for an intra-aor-
tic balloon pump or inotropic agents to keep the cardiac index
more than 2.0 L · min–1 · m–2 for greater than 24 hours after
the operation. Operative mortality was defined as death during
the initial hospitalization or within 30 days of the operation.
Statistical analysis. The c 2 test was used to evaluate poten-
tial confounders of the relationship between low serum albu-
min or the extremes of BMI and operative morbidity and
mortality. A variable was considered a potential confounder if
it was related to albumin or BMI and operative death or com-
plication with a P value ≤ .20.
To adjust for the potential confounding effects of other risk
factors, we used multivariable logistic regression to evaluate
operative mortality and morbidity risk associated with low
albumin levels and the extremes of BMI. The potential con-
founders included age, sex, ejection fraction, New York Heart
Association functional class, previous cardiac operation, pre-
operative diabetes, peripheral and cerebral vascular disease,
hypertension, renal failure, congestive heart failure, myo-
cardial infarction, chronic obstructive pulmonary disease,
smoking, urgency of operation, use of an internal thoracic
artery, and type of operation. The odds ratio for mortality
for each of the identified risk factors was then calculated.9
We also fit multivariable models with albumin as a continu-
ous variable and with BMI expressed with linear and then
cubic splines.10,11 Goodness of fit was assessed with the
Hosmer and Lemeshow goodness-of-fit c 2 test and by plot-
ting the Hosmer and Lemeshow D c 2 and D -D influence sta-
tistics and leverage against the predicted probability of
death or morbidity.12 The statistical analyses were per-
formed with the use of Stata version 5 (Stata Corporation,
College Station, Tex).
Results
Sixty-eight percent of the patients underwent isolat-
ed CABG procedures, 18% underwent isolated valve
operations, and 14% underwent combined CABG/
valve procedures. The median age of the patients was 67
years with a lower quartile of 59 years and an upper
quartile of 74 years. The median BMI was 26.6 with a
lower quartile of 23.9 and an upper quartile of 29.7. The
median serum albumin level was 3.5 g/dL with a lower
quartile of 2.7 g/dL and an upper quartile of 4.1 g/dL.
The overall mortality was 3.8%. Table I shows the
percent mortality in strata of BMI and preoperative
serum albumin. Low BMI (<20) and low albumin level
(<2.5 g/dL) were each associated with increased mor-
tality after cardiopulmonary bypass (P ≤ .0005). Those
with both low BMIs and low albumin levels had the
highest mortality (16%). At all levels of BMI the oper-
ative mortality was higher among patients with an albu-
min level less than 2.5 g/dL. At all levels of albumin the
operative mortality was higher in those with a BMI less
than 20 (Table I). Patients with extremely high BMIs
Table I. Percent operative mortality and number of
patients in each group (n) in strata of BMI and
preoperative serum albumin
BMI (kg/m2)
<20 20-30 >30 All patients
Albumin (g/dL)
< 2.5 16 (49) 7 (589) 8 (130) 7 (768)
2.5-3.5 9 (81) 3 (1365) 5 (464) 4 (1910)
> 3.5 7 (107) 3 (1777) 3 (606) 3 (2490)
All patients 10 (237) 3 (3731) 4 (1200) 4 (5168)
BMI, Body mass index.
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(>35) had a mortality of 4.7%, not significantly differ-
ent than the referent group (P = .16).
The preoperative demographics, risk factors, and
clinical presentation of the study group are presented in
Table II. Emergency/urgent operations were performed
within 24 hours of disease diagnosis. Women constitut-
ed the largest percentage of patients with a BMI less
than 20 (60%). In patients who underwent CABG or
CABG/valve procedures, there was no difference in
internal thoracic artery usage between patients with a
BMI of 20 to 30 and those with a BMI of more than 30.
Patients with a serum albumin level of less than 2.5
g/dL and a BMI of less than 20 had a greater number of
comorbidities and risk factors.
Lower levels of serum albumin were associated with
a higher incidence of postoperative complications and
greater lengths of stay (Table III). The highest preva-
lence of complications was seen in those patients with
Table II. Patient profile: Percent of patients in strata of albumin, body surface area, and operative outcome who
had the characteristics on the left (column percentages)
Albumin (g/dL) BMI (kg/m2) Operative death
< 2.5 2.5-3.5 > 3.5 < 20 20-30 >30 All patients Yes No
No. of patients 768 1910 2490 237 3731 1200 5168 196 4972
Percent of all patients 15 37 48 5 72 23 100 3.8 96.2
Demographics:
Percent female 40 32 30 60 29 36 32 42 31
Percent age > 75 y 27 23 23 42 25 16 25 40 23
BMI (kg/m2)
Percent thin (<20) 6 5 4 5 12 4
Percent 20-30 77 73 71 72 65 73
Percent obese (> 30) 17 22 25 23 23 23
Low serum albumin (g/dL)
Percent < 2.5 21 16 11 15 29 14
Percent 2.5-3.5 21 20 19 37 16 20
Percent > 3.5 58 64 70 48 55 66
Risk factors:
Percent EF < 30% 7 7 8 14 7 6 7 16 7
Percent NYHA functional 21 17 17 20 18 16 18 36 17
class IV
Percent previous cardiac surgery 17 16 16 23 16 14 16 36 15
Percent diabetes 30 26 28 16 24 40 28 34 27
Percent PVD 17 13 11 16 13 11 13 29 12
Percent cerebral vascular disease 16 12 10 15 12 9 11 23 11
Percent hypertension 61 60 57 44 57 66 58 70 58
Percent renal failure 12 10 8 15 9 8 9 22 9
Percent CHF 40 32 35 61 34 32 35 57 34
Percent previous MI 55 51 47 37 49 52 49 67 49
Percent COPD 11 10 10 17 10 11 10 15 10
Percent smoking history 63 64 64 58 63 67 64 64 64
Clinical presentation:
Percent elective operation 58 66 70 63 67 67 67 41 68
Percent emergency/urgent 42 34 30 37 33 33 33 59 32
operation
Intraoperative procedure:
Percent CABG 68 67 67 36 67 77 68 52 68
Percent valve 14 16 19 37 19 11 18 14 18
Percent CABG/valve 17 15 14 27 14 12 14 34 14
Percent ITA usage 73 77 82 58 79 80 79 49 80
Percent median pump time 34 28 29 41 30 27 30 68 21
(>120 min)
Percent median crossclamp time 30 26 24 37 25 23 25 47 24
(>90 min)
BMI, Body mass index; EF, ejection fraction; NYHA, New York Heart Association; PVD, peripheral vascular disease; CHF, congestive heart failure; MI, myocardial
infarction; COPD, chronic obstructive pulmonary disease; CABG, coronary artery bypass grafting; ITA, internal thoracic artery. Cerebral vascular disease includes
any patient with a previous cerebral vascular accident, transient ischemic attack, or carotid stenosis. Peripheral vascular disease: defined by a history of claudication
or prior peripheral bypass for occlusive arterial disease.
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serum albumin levels less than 2.5 g/dL. There was no
association between preoperative serum albumin levels
and saphenous vein harvest site infections. A BMI less
than 20 was also associated with an increased number
of postoperative complications. Patients with BMIs of
more than 30 had a significantly increased incidence of
deep sternal wound infection and saphenous vein har-
vest site infections (P ≤ .0005) without any increase in
overall length of stay.
In multivariable analyses adjusting for potential con-
founders, patients with a serum albumin level less than
3.5 g/dL had a significantly increased risk for renal
failure, postoperative atrial fibrillation, and increased
length of stay (Table IV). Patients with a serum albu-
min level of less than 2.5 g/dL also had an increased
risk of death, low cardiac output, and re-exploration for
bleeding. Patients with a BMI less than 20 had an
increased risk of death, cerebral vascular accident,
transient ischemic attack, renal failure, pneumonia, and
reoperation for bleeding. Patients with a BMI more
than 30 had an increased risk of atrial arrhythmias,
deep sternal wound infections, and saphenous vein har-
Table III. Percent of patients in strata of preoperative albumin and BMI with postoperative outcomes after CABG
and/or valve surgery (column percentages)
Albumin (g/dL) BMI (kg/m2)
Outcome <2.5 2.5-3.5 >3.5 P value* <20 20-30 >30 P value*
CVA/TIA 5.2 3.5 3.9 .11 9.1 3.8 3.3 ≤.0005
Renal failure 6.3 4.8 2.1 ≤.0005 8.6 3.5 3.3 ≤.0005
Pneumonia 4.3 3.8 2.8 .07 8.6 3.0 3.6 ≤.0005
Sepsis 3.5 2.9 2.2 .11 3.7 2.6 2.5 .55
Myocardial infarction 4.3 2.8 2.4 .02 3.3 2.6 3.3 .41
Low cardiac output 14.7 10.4 7.6 ≤.0005 16 9.4 9.6 .003
New atrial fibrillation 34 32 27 ≤.0005 32 29 30 .50
Re-exploration for bleeding 7.4 4.0 4.4 .001 11.5 5.0 2.7 ≤.0005
Deep sternal wound infection 3.3 3.3 2.0 .06 0.7 1.7 4.9 ≤.0005
Leg infection 4.4 4.1 3.8 .83 4.6 2.8 7.0 ≤.0005
ICU > 3 days 27 20 14 ≤.0005 31 18 17 ≤.0005
Ventilatory support > 1 day 33 23 14 ≤.0005 32 19 20 ≤.0005
Length of stay > 10 days 29 24 15 ≤.0005 34 20 19 ≤.0005
CVA, Cerebrovascular accident; TIA, transient ischemic attack; ICU, intensive care unit.
*The c 2 test was used to calculate the P values.
Table IV. Odds ratio and 95% confidence interval for postoperative outcomes after adjustment for confounders in
patients with low serum albumin or low/high BMI
Albumin (g/dL) BMI (kg/m2)
<2.5 2.5-3.5 <20 >30
Outcome OR (CI) P value OR (CI) P value OR (CI) P value OR (CI) P value
Death 2.0 (1.3-3.0) .002 1.1 (0.8-1.6) .6 2.0 (1.2-3.6) .009 1.4 (0.9-2.1) .1
CVA/TIA 1.1 (0.7-1.6) .7 0.8 (0.5-1.1) .1 1.7 (1.0-2.9) .03 0.9 (0.6-1.4) .7
Renal failure 2.0 (1.3-3.2) .002 1.9 (1.3-2.7) .001 2.0 (1.2-3.5) .01 1.1 (0.7-1.6) .7
Pneumonia 1.1 (0.7-1.8) .6 1.1 (0.8-1.5) .7 2.2 (1.3-3.8) .003 1.4 (0.9-2.0) .1
Sepsis 1.2 (0.7-2.0) .5 1.1 (0.76-1.7) .5 1.1 (0.5-2.3) .8 1.0 (0.6-1.5) .8
MI 1.5 (0.9-2.3) .1 1.0 (0.7-1.4) .9 1.5 (0.7-3.3) .3 1.2 (0.8-1.8) .3
Low cardiac output 1.6 (1.2-2.1) .001 1.2 (1.0-1.5) .1 1.3 (0.9-1.9) .2 1.1 (0.9-1.4) .5
New AF 1.4 (1.2-1.7) .0001 1.3 (1.2-1.5) .0001 1.0 (0.7-1.3) .9 1.2 (1.0-1.4) .02
Re-exploration for bleeding 1.4 (1.0-2.1) .04 0.8 (0.6-1.1) .3 2.1 (1.3-3.3) .001 0.6 (0.4-0.8) .005
Deep sternal wound infection 1.7 (0.8-3.6) .2 1.5 (0.9-2.5) .1 0.4 (0.1-3.0) .4 2.4 (1.5-3.8) .0001
Leg infection 1.1 (0.5-2.2) .8 1.0 (0.7-1.6) .8 2.0 (0.9-4.7) .1 2.1 (1.4-3.1) .0001
ICU > 3 days 1.7 (1.4-2.1) .0001 1.3 (1.1-1.6) .006 1.4 (1.0-1.9) .07 1.0 (0.8-1.2) .9
Ventilatory support > 1 day 2.5 (2.0-3.1) .0001 1.5 (1.2-1.7) .0001 1.3 (0.9-1.8) .1 1.1 (1.1-1.4) .2
Length of stay > 10 days 1.9 (1.5-2.4) .0001 1.6 (1.3-1.8) .0001 1.3 (0.9-1.9) .1 1.0 (0.9-1.3) .7
OR, Odds ratio; CI, 95% confidence interval; BMI, body mass index; CVA, cerebral vascular accident; TIA, transient ischemic attack; MI, myocardial infarction; AF,
atrial fibrillation; ICU, intensive care unit. The referent groups are patients with a normal serum albumin (>3.5 g/dL) and normal BMI (20-30). 
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vest site infections. Remarkably, these patients also had
a significantly decreased risk of re-exploration for
bleeding. These findings cannot be explained by differ-
ences in internal thoracic artery use, which was nearly
identical between patients with a BMI of 20 to 30 and
those with a BMI of more than 30.
The mortality results are independent of the type of
surgical procedure performed. The odds ratio for mor-
tality in the group with a BMI less than 20 was 2.8 after
CABG, 3.0 after isolated valve operations, and 1.4 after
combined CABG/valve procedures. The odds ratio for
mortality in the group with an albumin level less than
2.5 g/dL was 1.6 after CABG, 3.2 after isolated valve
operations, and 2.4 after combined CABG/valve proce-
dures. A low serum albumin level was a better predic-
tor of mortality in isolated valve and combined valve
procedures than in isolated CABG procedures. A BMI
of more than 30 or an albumin level of 2.5 to 3.5 g/dL
was not associated with a significantly increased mor-
tality in any surgical subgroup. There was no signifi-
cant interaction between BMI and albumin level.
Analyzing both BMI and albumin level as continuous
variables illustrated that the risk of death decreased lin-
early with increasing levels of albumin (odds ratio =
0.78 per albumin unit, P = .02). To adjust for the U-
shaped relationship between operative mortality and
BMI, we have used linear splines within the ranges of
less than 20, 20 to 30, and more than 30. We chose
these knots after examining the relationship between
operative mortality and BMI. The models provided
essentially the same information as those using cate-
gories of BMI and albumin. We have presented analy-
ses with categories of BMI and albumin in the tables
and figures for ease of interpretation.
To better understand the predictive value of a low
BMI or low albumin level for operative mortality rela-
tive to the other identified preoperative risk factors,
each of the odds ratios are listed from the highest to the
lowest value in Fig 1. A BMI less than 20 is among the
factors most highly associated with mortality, with an
odds ratio of 2.1 (P = .009). An albumin level of less
than 2.5 g/dL has an odds ratio of 2.0 (P = .002). A
BMI of more than 30 has an odds ratio of 1.3 (P = .15).
Discussion
The main finding in this study was that both low BMI
and hypoalbuminemia independently predicted
increased mortality and postoperative complications
after cardiac surgery. The thinnest patients were found
to have more risk factors for postoperative morbidity
Fig 1. Odds ratios and 95% confidence intervals for mortality after cardiac operations from the multivariable
model. CABG, Coronary artery bypass graft; BMI, body mass index; EF, ejection fraction; IMA, internal thoracic artery;
MI, myocardial infarction; NYHA, New York Heart Association; COPD, chronic obstructive pulmonary disease.
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and mortality. In addition, women represented a greater
percentage of patients in the low BMI group than the
other groups. Using multivariable analysis and adjust-
ing for these risk factors, we found that the increased
postoperative morbidity and mortality remained signif-
icant in patients with a low BMI and hypoalbuminemia.
Christakis and associates13 suggested a similar rela-
tionship between BMI and operative mortality/low car-
diac output after isolated CABG procedures. Other
studies3,14,15 have similarly implied that patients with
smaller body surface areas have a higher mortality
independent of other risk factors. Mickleborough and
colleagues16 found an increased incidence of perioper-
ative myocardial infarction and low cardiac output in
patients with low body surface areas after isolated
CABG, but no difference in mortality.
Multiple mechanisms likely explain the increased risk
of morbidity and mortality in patients with low BMI
undergoing cardiac operations. Despite our best efforts,
the influences of these patients’ greater number of
comorbidities cannot be fully adjusted. In addition, these
patients may be adversely affected by having smaller
coronary arteries and receiving smaller valves. However,
others have reported that there was no difference
between women and men in the percentage of small dis-
tal vessels.16 Patients with a low BMI may also be more
hemodiluted by a fixed bypass circuit during cardiopul-
monary bypass. This may result in greater postoperative
weight gain, transfusion requirements, and length of
stay. Another explanation may be that patients with low
BMIs (and a lower percentage of body fat) have less
nutritional reserve, which may not allow them to handle
complications as well, resulting in greater mortality.
In this study we found that obesity did not predict
increased mortality after cardiac surgery. There was,
however, an increased risk of atrial arrhythmias, deep
sternal wound infections, and saphenous vein harvest
site infections. Our findings are similar to those of
other recent reports.1,2,17 Surprisingly, obesity was
associated with a statistically significant reduction in
risk of re-exploration for bleeding. Similar findings
were reported by Birkmeyer and associates.2 Our study
did not take into consideration readmission rates or
postdischarge complications that may have been
increased in these obese individuals.
Preoperative malnutrition has been associated with
poor outcome after cardiac surgery.18 Serum albumin
levels have been shown to correlate with overall nutri-
tional status.19 Rich and coworkers4 have shown that
hypoalbuminemia predicts increased risk of periopera-
tive complications in elderly patients after cardiac
surgery. A study by Abel and colleagues20 concluded
that preoperative serum albumin measurements did not
correlate with postoperative morbidity and mortality in
a group of 100 patients. However, most of the patients
in this group had normal albumin levels. The study did
suggest, however, that thin male patients were at
greater risk for postoperative complications. In this
study we found that hypoalbuminemia is a significant
predictor of a number of postoperative complications.
In addition, a serum albumin level of less than 2.5 g/dL
increased the length of hospitalization and mortality.
These findings were independent of patient age, sex,
BMI, and multiple other potential confounders. A low
serum albumin level was a better predictor of mortality
in isolated valve and combined valve procedures than
in isolated CABG procedures. This study was limited
by relying on a single parameter to assess nutritional
status. In addition, albumin levels may be affected by
chronic congestive heart failure, hepatic insufficiency,
renal failure, and systemic illness.18
Low BMI and low preoperative serum albumin were
each independent of one another in their prediction of
increased morbidity and mortality after cardiac opera-
tions (correlation coefficient R = 0.07). The fact that
patients with a low BMI and normal albumin level still
had an increased mortality suggests that malnutrition
causing weight loss or cachexia is not the predominant
factor behind their poor outcome. More studies are need-
ed to determine the cause for the inferior outcome in thin
patients. Magovern and associates21 used both low BMI
(<24) and low serum albumin level (<4 g/dL) in their
overall risk stratification model for patients undergoing
isolated CABG. Even at these levels, low BMI and low
albumin level were significant predictors of adverse out-
come. Our study suggests that BMI and serum albumin
levels should be used to enhance risk stratification mod-
els for all patients undergoing cardiac operations.
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Discussion
Dr Lawrence I. Bonchek (Lancaster, Pa). We also have
evaluated BMI, although not serum albumin, as a risk factor.
When we started our study, we thought that high BMI would
demonstrate that our obese patients were at higher risk. We
found, as you did, that they were not, and that the higher risk
was in the low BMI group. 
We studied patients with coronary artery disease exclu-
sively. Would you comment on the fact that, by including
patients with valve disease as well as coronary disease, you
introduced the variable of heart failure? For instance, albu-
min could be a surrogate for end-stage heart failure and liver
congestion. I would suggest that if you evaluated your sub-
set of patients with coronary disease, you would have a purer
study. 
In addition, we found that the low BMI marker was partic-
ularly striking in older patients, and then even more striking
in older women, to the point that for a woman over the age of
70 years who has a BMI of less than 20, with pure coronary
disease, our mortality rate in that group is almost 20%. I
wonder what your results would be if you divided your data
by sex, by age, and by coronary disease alone. 
Dr Engelman. Thank you, Dr Bonchek. We did in fact
divide our patients by procedure type to evaluate the indi-
vidual contributions of our 2 risk factors, low BMI and low
serum albumin, on patients who had isolated CABG proce-
dures and isolated valve procedures. The effects of low
BMI and low albumin level on mortality were independent
of the type of surgical procedure. However, whereas the
odds ratios of 2.8 and 3 were about the same for low BMI,
low preoperative serum albumin level was much more pre-
dictive of mortality in patients who had isolated valve pro-
cedures than in patients who had isolated CABG proce-
dures. We are not exactly sure of the reason for that.
However, BMI seems to have been an indiscriminate indi-
cator of risk. 
In answer to your second question, we did divide the
patients by sex and age and did not find that sex significant-
ly altered the results, although female patients were at slight-
ly increased risk for mortality after both CABG and valve
procedures, and older patients were at still more risk. The
combination of female sex and low BMI, however, was not
associated with increased risk.  
Dr James A. Magovern (Pittsburgh, Pa). I want to confirm
the findings that you have reported. We published an article a
number of years ago on a risk model for predicting morbidi-
ty and mortality, and we also found that low serum albumin
level and low BMI were independent predictors based on a
multivariate regression analysis. We have not been able to
determine a plausible mechanism by which a low BMI is
associated with increased mortality, but I think it is a clear
finding. My own view is that BMI is probably a marker for
multiple factors. 
In our experience, these patients frequently have a long his-
tory of smoking, hypertension, carotid disease, and peripher-
al vascular disease. I think low BMI is a surrogate for 4 or 5
comarkers. You probably need more data points to ferret that
out. 
Do you have a mechanism by which low BMI translates
into increased risk?  
Dr Engelman. We did our best to adjust for all of these
increased risk factors. There is no question that patients with
a low BMI had increased risk factors. A percentage of these
patients had peripheral vascular disease and cerebrovascular
disease, although they were less likely to have diabetes. We
attempted to adjust in this large group for each of these risk
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factors. In taking these out, we do agree, though, that there
are other risk factors that we could not account for which may
contribute to their increased mortality. 
Other possible reasons that a patient with a low BMI
would have an increased risk after cardiac surgery, indepen-
dent of all of these risk factors, are the following: Potentially
the patients have smaller targets in CABG, they receive
smaller valves, or they have smaller aortas with which to
work during combined valve and CABG procedures or iso-
lated valve procedures. They receive potentially more hemo-
dilution on the fixed cardiopulmonary bypass pump during
the operation and potentially receive more transfusions to
maintain their hemoglobin levels. In addition, a low BMI is
probably a marker for nutritional reserve or underlying
cachexia in a way that preoperative serum albumin could not
assess. For this reason, in our study low serum albumin level
was an independent risk factor for mortality and did not
seem to depend on low BMI.
Notice of correction
In the May 1998 issue of the Journal, in the article by Liam and associates titled “Hemodilution and Whole Body
Oxygen Balance During Normothermic Cardiopulmonary Bypass in Dogs” (J Thorac Cardiovasc Surg 1998;115:
1203-8), an error in units of measurement was made. On page 1206, column 2, lines 5 and 7, the unit of measure-
ment should be “kg” rather than “100 gm.” The text on line 5 should read “10 mL · kg–1 · min–1.” The text on line 7
should read “(9.8 mL · kg–1 · min–1).”
